PULM (Pulmatrix Corp) Net Margin

Public company logo of Pulmatrix Inc (PULM)

Pulmatrix, Inc. (PULM) is a macro-resilient biotech company developing inhalation therapies for the lungs regardless of economic cycles. An innovative drug delivery system in the US ensures production stability. Net profit margins on shipments visualize this effect, with the current value standing at 0.00. The company is currently restructuring its assets, shifting from development toward the licensing of its iSPERSE technology and the search for partners.

pulmatrix.com (PULM) - Net Sales Margin from 07/04/2022 to 11/19/2026

Pulmatrix Corp (PULM) - metric breakdowns and financial figures

- market value and analyst target forecast:
Analysis of all company metrics:Pulmatrix Corp, PULM
Manufactured product of Pulmatrix Inc

Selecting stocks with a high margin of safety begins with analyzing the efficiency of revenue conversion into net income. This indicator measures the portion of income remaining after covering all operating expenses and interest. For Pulmatrix, Inc. (PULM), this metric is sensitive to logistic disruptions in reagent procurement and the complexities of international trials. Temporary dips may reflect one-time costs rather than a systemic crisis. The net margin dynamics clearly visualize these market fluctuations.

Key competitors

HLN: Net Sales Margin|Net Return on Sales KVUE|Net Margin veronapharma.com|Net Return on Sales MENS (Jyong Biotech Corp)|Net Margin Ligand (LGND)|Net Sales Margin amneal.com (AMRX)|Net Sales Margin PRGO (perrigo.com)|Alvotech SA (ALVO) - Net Margin|Liquidia Inc. - Net Sales Margin|Net Profitability Margin Galapagos Corp (GLPG)|ANI Pharmaceuticals (ANIP) - Net Margin|Net Return on Sales MNKD|Net Margin Amphastar Pharmaceuticals, Inc.|Pacira Pharmaceuticals (PCRX) - Company Sales Margin|Net Sales Margin SPRY|TBPH - Net Margin|Aquestive Pharma - Return on Sales by Net Profit|Net Sales Margin scpharmaceuticals.com SCPH|Tectonic - Net Sales Margin|TNXP - Net Sales Margin|SXTC: Net Sales Margin|Eupraxia Pharma - Net Profit Rate|BHST (bioharvest.com) - Net Sales Margin|Net Return on Sales EXOZ (invizyne.com)|Net Sales Margin ORMP|Company Sales Margin Entera Bio|Net Sales Margin HYFT (MindWalk Holdings, Inc.)|ABVC BioPharma - Net Margin|Cumberland Corp - Net Sales Margin|QNTM - Net Sales Margin|FibroGen, Inc. (FGEN) - Net Margin|TELO: Company Net Profitability|RANI (Rani Therapeutics Inc) - Net Sales Margin|Net Margin synergychc.com SNYR|Net Margin Rallybio Corp. (RLYB)|LEXX - Net Margin|Pheton Holdings - Return on Sales by Net Profit|Net Sales Margin Aptorum Group Limited APM|LYRA: Return on Sales by Net Profit|IBO: Net Margin|TNFA: Net Sales Margin|YCBD: Company Net Profitability|Net Margin PainReform Ltd|CYTO (altamiratherapeutics.com) - Company Net Profitability|Net Sales Margin LIPO|OPTN - Net Margin|Net Margin pieris.com PIRS|Net Profit Rate PROC|PTPI - Net Margin|Qilian International Holding (QLI) - Return on Sales by Net Profit|SLRN: Net Sales Margin|Return on Sales by Net Profit TFF Pharma